(Q40170491)

English

A phase I clinical trial of CD1c (BDCA-1)+ dendritic cells pulsed with HLA-A*0201 peptides for immunotherapy of metastatic hormone refractory prostate cancer

scientific article published on February 2015

Statements

A phase I clinical trial of CD1c (BDCA-1)+ dendritic cells pulsed with HLA-A*0201 peptides for immunotherapy of metastatic hormone refractory prostate cancer (English)
1 February 2015

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit